Delaware Chief Justice Collins J. Seitz Jr. Courtesy photo.
“Context” was the word Delaware Supreme Court Chief Justice Collins J. Seitz Jr. used most often Wednesday during argument over the Zimmer Biomet Holdings Inc. derivative case that was dismissed last year.
Much of the argument from the medical device company shareholders’ attorney, Richard Speirs of Cohen Milstein Sellers & Toll, centered on allegations that Zimmer’s officers and directors knew of FDA compliance issues but failed to disclose them, resulting in an insider knowledge stock dump totaling $3.3 billion.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
